These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2974416

  • 1. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride.
    Eggers C, Rothenberger A, Berghaus U.
    Eur Arch Psychiatry Neurol Sci; 1988; 237(4):223-9. PubMed ID: 2974416
    [Abstract] [Full Text] [Related]

  • 2. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W, Auberger S, Haag H, Rüther E.
    Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
    [Abstract] [Full Text] [Related]

  • 3. [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China].
    Liu ZS, Chen YH, Zhong YQ, Zou LP, Wang H, Sun D, Wang DB, Liao JX.
    Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):572-6. PubMed ID: 22093417
    [Abstract] [Full Text] [Related]

  • 4. [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].
    Müller-Vahl KR.
    Nervenarzt; 2007 Mar; 78(3):264, 266-8, 270-1. PubMed ID: 16924461
    [Abstract] [Full Text] [Related]

  • 5. Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea.
    Deroover J, Baro F, Bourguignon RP, Smets P.
    Curr Med Res Opin; 1984 Mar; 9(5):329-38. PubMed ID: 6241563
    [Abstract] [Full Text] [Related]

  • 6. Tiapride in levodopa-induced involuntary movements.
    Mejer Nielsen B.
    Acta Neurol Scand; 1983 Jun; 67(6):372-5. PubMed ID: 6351529
    [Abstract] [Full Text] [Related]

  • 7. Effects of tiapride in tardive dyskinesia.
    Pollak P, Gaio JM, Hommel M, Pellat J, Perret J.
    Psychopharmacology (Berl); 1985 Jun; 85(2):236-9. PubMed ID: 3925489
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tiapride in the long-term management of alcoholics of anxious or depressive temperament.
    Shaw GK, Majumdar SK, Waller S, MacGarvie J, Dunn G.
    Br J Psychiatry; 1987 Feb; 150():164-8. PubMed ID: 3307976
    [Abstract] [Full Text] [Related]

  • 10. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.
    Peters DH, Faulds D.
    Drugs; 1994 Jun; 47(6):1010-32. PubMed ID: 7521826
    [Abstract] [Full Text] [Related]

  • 11. Tiapride in the treatment of Huntington's chorea.
    Roos RA, Buruma OJ, Bruyn GW, Kemp B, van der Velde EA.
    Acta Neurol Scand; 1982 Jan; 65(1):45-50. PubMed ID: 6461156
    [Abstract] [Full Text] [Related]

  • 12. Tiapride versus glafenine: a double-blind comparative study in the management of acute rheumatic pain.
    Ginsberg F, Bourguignon RP, Smets P, Famaey JP.
    Curr Med Res Opin; 1983 Jan; 8(8):562-9. PubMed ID: 6140128
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
    Bock N, Moll GH, Wicker M, Pilz J, Rüther E, Banaschewski T, Huether G, Rothenberger A.
    Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.
    Bender S, Scherbaum N, Soyka M, Rüther E, Mann K, Gastpar M.
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):653-60. PubMed ID: 17076934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
    Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE.
    Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.